Articles by PRNEWSWIRE
PRNEWSWIRE
PRNEWSWIRE-
Rendeavour expands high-speed internet access to local communities around Tatu City, Kenya
Fahari Link, Tatu City's new internet company, bridges the digital divide for thousands of underserved residents TATU CITY, Kenya, April 25, 2024 /PRNewswire/ -- Rendeavour, Africa's largest new city builder and the owner and developer of Tatu City, the 5,000-acre new city on Nairobi's doorstep, has created a new company to deliver high-speed internet connectivity to thousands of digitally underserved residents in nearby towns and informal settlements. (Left to r
PR Newswire April 26, 2024
-
Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)
SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in adults. JAQBO is a next-generation potassium competitive blocker (P-CAB) expected to become the new standard treatment in the market for gastric acid related diseases. JAQBO directly bi
PR Newswire April 26, 2024
-
Zoomlion Shines at INTERMAT 2024 with a Vision for a Greener, Smarter Future
PARIS, April 25, 2024 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion", 01157.HK) proudly showcased its latest advancements at INTERMAT, held at the Nord Villepinte Exhibition Center in Paris from April 24-27, 2024. Themed "Greener Development, Brighter Future", the display featured approximately 30 cutting-edge products across seven major categories, underscoring Zoomlion's commitment to sustainable and intelligent product solutions.
PR Newswire April 26, 2024
-
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
"Aiming to offer a Dengue antiviral treatment course in $100 price range" Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Deng
PR Newswire April 26, 2024
-
THE WORLD'S 50 BEST RESTAURANTS NAMES 'CHAMPIONS OF CHANGE' WINNERS 2024
LONDON, April 25, 2024 /PRNewswire/ -- The World's 50 Best Restaurants today announces its Champions of Change 2024, the heroes of hospitality at the forefront of positive action and long-term progress within the industry and their communities. The World’s 50 Best Restaurants announces João Diamante, founder of Diamantes Na Cozinha in Rio de Janeiro and duo Caroline Caporossi and Jessica Rosval behind Roots in Modena, as Champions of Change winners for 2024 Part of
PR Newswire April 26, 2024
-
Huawei Unveils its Intelligent Distribution Solution at 26th World Energy Congress
ROTTERDAM, Netherlands, April 25, 2024 /PRNewswire/ -- Huawei is presenting its innovative Intelligent Distribution Solution (IDS) at the 26th World Energy Congress in Rotterdam. Developed in collaboration with ecosystem partners, the IDS aims to tackle the electric power industry's most pressing challenges, including high line loss, unreliable service, and the burden of managing new energy loads. Huawei presents its full-scenario solutions for the electric power sector at the 26th World E
PR Newswire April 25, 2024
-
Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicine
SHIJIAZHUANG, China, April 25, 2024 /PRNewswire/ -- On April 21, the 3rd Traditional Chinese Medicine Anti-Aging Conference, hosted by the World Federation of Chinese Medicine Societies, was held in Shijiazhuang. Yiling Pharmaceutical's Bazi Bushen capsule, as a representative drug of anti-aging innovative TCM widely recognized in the industry, became one of the focuses of the meeting. At the conference, many experts and scholars shared the theoretical basis and clinical research results of Bazi
PR Newswire April 25, 2024
-
iQIYI Launches Over 300 Titles at 2024 World Conference, Fueling Growth with Diverse Content and Robust IP Monetization
Two new drama brands focusing on literary work adaptations and short series respectively Using generative AI to optimize content production and empower creators BEIJING, April 25, 2024 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service in China, announced an exciting lineup of over 300 new titles across genres at the iQIYI 2024 World Conference held on April 23-24. The company also introduced two new drama series brands and forged multiple strategic partnerships
PR Newswire April 25, 2024
-
Huawei Cloud Stack 8.3 Is Officially Released in Hong Kong, with Six Highlights Inspiring a Leap to Cloud
HONG KONG, April 25, 2024 /PRNewswire/ -- At Huawei Cloud Summit 2024 in Hong Kong, Hu Yuhai, Vice President of Huawei Hybrid Cloud, announced the release of Huawei Cloud Stack 8.3 in Hong Kong. Huawei Cloud Stack 8.3 provides more than 110 on-premises cloud services and six highlights, aiming to help government organizations and companies in Hong Kong dive into cloud and spur innovation. Huawei Cloud also launched a "Leap2Cloud" initiative to help more customers and partners in Hong
PR Newswire April 25, 2024
-
CNOOC Limited Achieves Strong Growth in both Net Production and Net Profit in Q1 2024
HONG KONG, April 25, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announced its operating results for the first quarter of 2024. In the first quarter, the Company pressed ahead with oil and gas exploration and development, advanced the enhancement of quality and efficiency, and consolidated its advantage of cost competitiveness. Net production of oil and gas and net profit attributable to equity s
PR Newswire April 25, 2024
-
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatment due to p53 gene mutations SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost
PR Newswire April 25, 2024
-
POSCO International achieves solid first quarter results for fiscal year 2024 despite global economic downturn
On the 25th, announced 1Q revenue of 7.8 trillion won and operating profit of 265 billion won Stable profit structure of the energy business value chain and increased sales to the eco-friendly industry customers contributed to profit growth Secured a stable cash flow foundation to support future investment and improve shareholder returns SEOUL and INCHEON, South Korea, April 25, 2024 /PRNewswire/ -- Despite the ongoing global economic slowdown due to high interest rate and increased
PR Newswire April 25, 2024
-
Huawei Mainframe Modernization Solution Debuts at Huawei Cloud Summit Hong Kong
HONG KONG, April 25, 2024 /PRNewswire/ -- Today, at the Huawei Cloud Summit Hong Kong, themed "Leap to Intelligence", Lv Jinjiang, CTO of Huawei Mainframe Modernization BU for International Business and CTO of Huawei Hybrid Cloud for International Business, delivered a keynote speech titled "Mainframe Modernization, Transforming Financial Core Systems Faster." In this speech, Lv introduced Huawei's mainframe modernization solution. Lv Jinjiang, CTO of Huawei Ma
PR Newswire April 25, 2024
-
Aetina Accelerates Embedded AI with High-performance, Small Form-factor Aetina IA380E-QUFL Graphics Card
TAIPEI, April 25, 2024 /PRNewswire/ -- Aetina, a leading Edge AI solution provider, announced the launch of the Aetina IA380E-QUFL at Embedded World 2024 in Nuremberg, Germany. This groundbreaking product is a small form factor PCIe graphics card powered by the high-performance Intel Arc A380E GPU. High-performance, Small Form-factor Aetina IA380E-QUFL Graphics Card Unmatched Power in a Compact Design The Aetina IA380E-QUFL delivers workstation-level performance packed
PR Newswire April 25, 2024
-
Perx Technologies Elevates Loyalty with Perx Orion™: The AI-Driven Customer Intelligence Solution Transforming Engagement and Brand Experiences
SINGAPORE , April 25, 2024 /PRNewswire/ -- Perx Technologies, a leader in loyalty engagement and customer behavioral intelligence, is proud to introduce the world's first Autonomous Loyalty Framework, Perx Orion™. This cutting-edge Customer Intelligence Solution leverages AI to seamlessly integrate technology, intelligent customer data, and analytics. Combined with a creative ImpactLab™, Perx Orion™ empowers brands to forge authentic connections with their ecosystems and unlock new revenue
PR Newswire April 25, 2024
Most Popular
-
1
[KH Explains] No more 'Michael' at Kakao Games
-
2
Yoon, Lee end first talks with differences, agree to meet more
-
3
What is Hybe’s next move?
-
4
China outpaces Korea in smaller OLED shipments for 1st time
-
5
[Grace Kao] Hybe vs. Ador: Inspiration, imitation and plagiarism
-
6
[Herald Interview] Mom’s Touch seeks to replicate success in Japan
-
7
Police to open alleged stalking probe over pastor over Dior bag scandal
-
8
'Queen of Tears' finale sets record viewership ratings as tvN's most-watched series ending
-
9
[News Focus] Lee tells Yoon that he has governed without political dialogue
-
10
KT launches new mobile plans for foreign residents